Bioprocessing - Upstream & Downstream

We track the rapid rise of single use systems – and explore their role in the biomanufacturing facility of the future

Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion.

What separates a good model from a bad model in bioprocess development?

We investigate the advantages and limitations of microcalorimetry in biopharma.

Is there a future for Protein A in affinity chromatography?

Are you up-to-date with new analytical platforms that can give you the edge?

Batch or continuous processing? For mAbs, a hybrid approach could be best.

Protection at the genetic level – a new line of defense against contamination in biopharmaceutical manufacturing

Nominations for the 2017 Power List are now open and will close on February 1, 2017.

When an industry grows rapidly, innovative approaches are required to ensure sustainable growth. Here, we speak to leaders at Ireland’s National Institute for Bioprocess Research and Training – NIBRT – to find out how a focus on talent, training and technology is changing the face of the field.